Gulf States Will Pay Syrian Rebels, Defectors
After an international conference in Turkey, the Syrian National Council said it will receive millions a month in funding from wealthy Gulf nations to pay Syrians who are either rebelling against or defecting from President Bashar al-Assad's rule.After an international conference in Turkey, the Syrian National Council said it will receive millions a month in funding from wealthy Gulf nations to pay Syrians who are either rebelling against or defecting from President Bashar al-Assad’s rule.
The BBC reports that the compromise decision by some 70 foreign governments stops short of arming the rebels:
BBC: An SNC leader told the BBC that she hoped more substantial funding would help bind the disparate units of the Free Syrian Army into a more coherent fighting force, and encourage other soldiers to defect from the government side.
Some countries at the conference – notably Saudi Arabia – have been openly calling for insurgents in Syria to be given weapons. But others – including the US and Turkey – oppose the move, fearing it could fuel an all-out civil war. Read more
Secretary of State Hillary Clinton, speaking from Istanbul on Sunday, outlined Washington’s commitments emerging from the conference, which include “additional sanctions on senior regime officials, a new accountability clearinghouse to train Syrian citizens to document atrocities and abuses and to identify perpetrators, and more than $12 million in new humanitarian aid, bringing our total to nearly 25 million.” — PZS
Your support is crucial…With an uncertain future and a new administration casting doubt on press freedoms, the danger is clear: The truth is at risk.
Now is the time to give. Your tax-deductible support allows us to dig deeper, delivering fearless investigative reporting and analysis that exposes what’s really happening — without compromise.
Stand with our courageous journalists. Donate today to protect a free press, uphold democracy and unearth untold stories.
You need to be a supporter to comment.
There are currently no responses to this article.
Be the first to respond.